Lilly confident in slow and steady Foundayo launch, as ex-US sales shine

EarningsFoundayoPositive

AI Analysis

Summary

Lilly's Foundayo generated $98 million in Q2 2026 sales during its first quarter on market, with strong international performance, though trailing competitor Novo Nordisk's $355 million for the same period.

Financial Highlights

Revenue

$98 million

Importance:5/10

Sentiment:

0.60

product_launchcommercial_performanceQ2_resultsinternational_sales

Related Companies

$LLY

Read the original article

Published by BioSpace on August 5, 2026 6:14 PM

Read Original